Human perivascular stem cell-based bone graft substitute induces rat spinal fusion

Choon G. Chung, Aaron James, Greg Asatrian, Le Chang, Alan Nguyen, Khoi Le, Georgina Bayani, Robert Lee, David Stoker, Xinli Zhang, Kang Ting, Bruno Péault, Chia Soo

Research output: Contribution to journalArticle

Abstract

Adipose tissue is an attractive source of mesenchymal stem cells (MSCs) because of its abundance and accessibility. We have previously defined a population of native MSCs termed perivascular stem cells (PSCs), purified from diverse human tissues, including adipose tissue. Human PSCs (hPSCs) are a bipartite cell population composed of pericytes (CD146+CD34−CD45−) and adventitial cells (CD146−CD34+CD45−), isolated by fluorescence-activated cell sorting and with properties identical to those of culture identified MSCs. Our previous studies showed that hPSCs exhibit improved bone formation compared with a sample-matched unpurified population (termed stromal vascular fraction); however, it is not known whether hPSCs would be efficacious in a spinal fusion model. To investigate, we evaluated the osteogenic potential of freshly sorted hPSCs without culture expansion and differentiation in a rat model of posterolateral lumbar spinal fusion. We compared increasing dosages of implanted hPSCs to assess for dose-dependent efficacy. All hPSC treatment groups induced successful spinal fusion, assessed by manual palpation and microcomputed tomography. Computerized biomechanical simulation (finite element analysis) further demonstrated bone fusion with hPSC treatment. Histological analyses showed robust endochondral ossification in hPSC-treated samples. Finally, we confirmed that implanted hPSCs indeed differentiated into osteoblasts and osteocytes; however, the majority of the new bone formation was of host origin. These results suggest that implanted hPSCs positively regulate bone formation via direct and paracrine mechanisms. In summary, hPSCs are a readily available MSC population that effectively forms bone without requirements for culture or predifferentiation. Thus, hPSC-based products show promise for future efforts in clinical bone regeneration and repair.

Original languageEnglish (US)
Pages (from-to)1231-1241
Number of pages11
JournalStem cells translational medicine
Volume3
Issue number10
DOIs
StatePublished - Oct 2 2014
Externally publishedYes

Fingerprint

Bone Substitutes
Spinal Fusion
Stem Cells
Transplants
Mesenchymal Stromal Cells
Osteogenesis
Population
Adipose Tissue
Bone and Bones
Osteocytes
X-Ray Microtomography
Adventitia
Pericytes
Finite Element Analysis
Bone Regeneration
Palpation
Osteoblasts
Blood Vessels

Keywords

  • Adventitial cell
  • Mesenchymal stem cell
  • Osteogenesis
  • Pericyte
  • Perivascular stem cell
  • Tissue engineering

ASJC Scopus subject areas

  • Developmental Biology
  • Cell Biology

Cite this

Human perivascular stem cell-based bone graft substitute induces rat spinal fusion. / Chung, Choon G.; James, Aaron; Asatrian, Greg; Chang, Le; Nguyen, Alan; Le, Khoi; Bayani, Georgina; Lee, Robert; Stoker, David; Zhang, Xinli; Ting, Kang; Péault, Bruno; Soo, Chia.

In: Stem cells translational medicine, Vol. 3, No. 10, 02.10.2014, p. 1231-1241.

Research output: Contribution to journalArticle

Chung, CG, James, A, Asatrian, G, Chang, L, Nguyen, A, Le, K, Bayani, G, Lee, R, Stoker, D, Zhang, X, Ting, K, Péault, B & Soo, C 2014, 'Human perivascular stem cell-based bone graft substitute induces rat spinal fusion', Stem cells translational medicine, vol. 3, no. 10, pp. 1231-1241. https://doi.org/10.5966/sctm.2014-0027
Chung, Choon G. ; James, Aaron ; Asatrian, Greg ; Chang, Le ; Nguyen, Alan ; Le, Khoi ; Bayani, Georgina ; Lee, Robert ; Stoker, David ; Zhang, Xinli ; Ting, Kang ; Péault, Bruno ; Soo, Chia. / Human perivascular stem cell-based bone graft substitute induces rat spinal fusion. In: Stem cells translational medicine. 2014 ; Vol. 3, No. 10. pp. 1231-1241.
@article{90506aa9218d4a02a387a1c795ca65ec,
title = "Human perivascular stem cell-based bone graft substitute induces rat spinal fusion",
abstract = "Adipose tissue is an attractive source of mesenchymal stem cells (MSCs) because of its abundance and accessibility. We have previously defined a population of native MSCs termed perivascular stem cells (PSCs), purified from diverse human tissues, including adipose tissue. Human PSCs (hPSCs) are a bipartite cell population composed of pericytes (CD146+CD34−CD45−) and adventitial cells (CD146−CD34+CD45−), isolated by fluorescence-activated cell sorting and with properties identical to those of culture identified MSCs. Our previous studies showed that hPSCs exhibit improved bone formation compared with a sample-matched unpurified population (termed stromal vascular fraction); however, it is not known whether hPSCs would be efficacious in a spinal fusion model. To investigate, we evaluated the osteogenic potential of freshly sorted hPSCs without culture expansion and differentiation in a rat model of posterolateral lumbar spinal fusion. We compared increasing dosages of implanted hPSCs to assess for dose-dependent efficacy. All hPSC treatment groups induced successful spinal fusion, assessed by manual palpation and microcomputed tomography. Computerized biomechanical simulation (finite element analysis) further demonstrated bone fusion with hPSC treatment. Histological analyses showed robust endochondral ossification in hPSC-treated samples. Finally, we confirmed that implanted hPSCs indeed differentiated into osteoblasts and osteocytes; however, the majority of the new bone formation was of host origin. These results suggest that implanted hPSCs positively regulate bone formation via direct and paracrine mechanisms. In summary, hPSCs are a readily available MSC population that effectively forms bone without requirements for culture or predifferentiation. Thus, hPSC-based products show promise for future efforts in clinical bone regeneration and repair.",
keywords = "Adventitial cell, Mesenchymal stem cell, Osteogenesis, Pericyte, Perivascular stem cell, Tissue engineering",
author = "Chung, {Choon G.} and Aaron James and Greg Asatrian and Le Chang and Alan Nguyen and Khoi Le and Georgina Bayani and Robert Lee and David Stoker and Xinli Zhang and Kang Ting and Bruno P{\'e}ault and Chia Soo",
year = "2014",
month = "10",
day = "2",
doi = "10.5966/sctm.2014-0027",
language = "English (US)",
volume = "3",
pages = "1231--1241",
journal = "Stem cells translational medicine",
issn = "2157-6564",
publisher = "AlphaMed Press",
number = "10",

}

TY - JOUR

T1 - Human perivascular stem cell-based bone graft substitute induces rat spinal fusion

AU - Chung, Choon G.

AU - James, Aaron

AU - Asatrian, Greg

AU - Chang, Le

AU - Nguyen, Alan

AU - Le, Khoi

AU - Bayani, Georgina

AU - Lee, Robert

AU - Stoker, David

AU - Zhang, Xinli

AU - Ting, Kang

AU - Péault, Bruno

AU - Soo, Chia

PY - 2014/10/2

Y1 - 2014/10/2

N2 - Adipose tissue is an attractive source of mesenchymal stem cells (MSCs) because of its abundance and accessibility. We have previously defined a population of native MSCs termed perivascular stem cells (PSCs), purified from diverse human tissues, including adipose tissue. Human PSCs (hPSCs) are a bipartite cell population composed of pericytes (CD146+CD34−CD45−) and adventitial cells (CD146−CD34+CD45−), isolated by fluorescence-activated cell sorting and with properties identical to those of culture identified MSCs. Our previous studies showed that hPSCs exhibit improved bone formation compared with a sample-matched unpurified population (termed stromal vascular fraction); however, it is not known whether hPSCs would be efficacious in a spinal fusion model. To investigate, we evaluated the osteogenic potential of freshly sorted hPSCs without culture expansion and differentiation in a rat model of posterolateral lumbar spinal fusion. We compared increasing dosages of implanted hPSCs to assess for dose-dependent efficacy. All hPSC treatment groups induced successful spinal fusion, assessed by manual palpation and microcomputed tomography. Computerized biomechanical simulation (finite element analysis) further demonstrated bone fusion with hPSC treatment. Histological analyses showed robust endochondral ossification in hPSC-treated samples. Finally, we confirmed that implanted hPSCs indeed differentiated into osteoblasts and osteocytes; however, the majority of the new bone formation was of host origin. These results suggest that implanted hPSCs positively regulate bone formation via direct and paracrine mechanisms. In summary, hPSCs are a readily available MSC population that effectively forms bone without requirements for culture or predifferentiation. Thus, hPSC-based products show promise for future efforts in clinical bone regeneration and repair.

AB - Adipose tissue is an attractive source of mesenchymal stem cells (MSCs) because of its abundance and accessibility. We have previously defined a population of native MSCs termed perivascular stem cells (PSCs), purified from diverse human tissues, including adipose tissue. Human PSCs (hPSCs) are a bipartite cell population composed of pericytes (CD146+CD34−CD45−) and adventitial cells (CD146−CD34+CD45−), isolated by fluorescence-activated cell sorting and with properties identical to those of culture identified MSCs. Our previous studies showed that hPSCs exhibit improved bone formation compared with a sample-matched unpurified population (termed stromal vascular fraction); however, it is not known whether hPSCs would be efficacious in a spinal fusion model. To investigate, we evaluated the osteogenic potential of freshly sorted hPSCs without culture expansion and differentiation in a rat model of posterolateral lumbar spinal fusion. We compared increasing dosages of implanted hPSCs to assess for dose-dependent efficacy. All hPSC treatment groups induced successful spinal fusion, assessed by manual palpation and microcomputed tomography. Computerized biomechanical simulation (finite element analysis) further demonstrated bone fusion with hPSC treatment. Histological analyses showed robust endochondral ossification in hPSC-treated samples. Finally, we confirmed that implanted hPSCs indeed differentiated into osteoblasts and osteocytes; however, the majority of the new bone formation was of host origin. These results suggest that implanted hPSCs positively regulate bone formation via direct and paracrine mechanisms. In summary, hPSCs are a readily available MSC population that effectively forms bone without requirements for culture or predifferentiation. Thus, hPSC-based products show promise for future efforts in clinical bone regeneration and repair.

KW - Adventitial cell

KW - Mesenchymal stem cell

KW - Osteogenesis

KW - Pericyte

KW - Perivascular stem cell

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=84908046585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908046585&partnerID=8YFLogxK

U2 - 10.5966/sctm.2014-0027

DO - 10.5966/sctm.2014-0027

M3 - Article

C2 - 25154782

AN - SCOPUS:84908046585

VL - 3

SP - 1231

EP - 1241

JO - Stem cells translational medicine

JF - Stem cells translational medicine

SN - 2157-6564

IS - 10

ER -